Video Shorts

1:28
New Drug Clears Chronic Hand Eczema in 16 Weeks
6 months ago
by
Linda Stein Gold, MD

1:50
Diabetes Dialogue: Screening for MASH is Easier Than You Think
6 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:52
Nephrologist Reacts to Pegcetacoplan’s Approval in C3 Glomerulopathy
6 months ago
by
Sayna Norouzi, MD

1:30
Liver Lineup: How Semaglutide Improves Liver Health Beyond Weight Loss
6 months ago
by
Nancy Reau, MD(+2 more)

2:13
Preview of Medical Sisterhood, With Laura Ferris, MD, PhD
6 months ago
by
Mona Shahriari, MD, FAAD(+1 more)

1:46
ESSENCE and Semaglutide 2.4 mg for MASH
6 months ago
by
Arun Sanyal, MD

2:10
ATTAIN-1 Topline Results Shed Light on Orforglipron in Obesity
6 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:32
Short #4
7 months ago
by
Silas Inman
Advertisement
Advertisement
Trending on HCPLive
1
Real-World HAE Control with Berotralstat at 18 Months, With Raffi Tachdjian, MD
2
Pediatric HAE Guideline Recommends Sebetralstat as First-Line Therapy
3
Mechanistic Rationale for Dual Costimulation Blockade, Belatacept, Dazodalibep in Kidney Transplantation
4
COMP360 Psilocybin Meets Primary Endpoint in Second Phase 3 Trial for TRD
5
